Form 4: USANA Health Sciences Director Nixon J Scott Reports Stock Transactions

Director Nixon J Scott of USANA Health Sciences reports the vesting and disposal of restricted stock units on August 2, 2024.

Summary

• On August 2, 2024, Nixon J Scott, a director of USANA Health Sciences Inc., reported transactions involving restricted stock units.
• Scott disposed of 674 shares of common stock related to the vesting of restricted stock units.
• Following the reported transaction, Scott directly owns 2,023 derivative securities.
• The restricted stock units vest in four equal installments on August 2, 2024, November 2, 2024, February 2, 2025, and May 2, 2025.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency to investors regarding insider transactions.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in compliance with SEC regulations.
• The vesting schedule of the restricted stock units (25% quarterly) is a common vesting structure.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions.
• The transactions themselves are unlikely to have a significant impact on other stakeholders.

Key Dates